DNA damage and repair markers to improve accuracy of prostate cancer diagnosis and identification of aggressive disease.

被引:0
|
作者
Algotar, Amit Mohan
Cress, Anne
Nagle, Ray
Sokoloff, Mitchell
Behnejad, Roxanna
Drinkwitz, Daniel
Lodhia, Naran
Thompson, Patricia
Stratton, Steven Paul
机构
[1] Univ Arizona, Ctr Canc, Tucson, AZ USA
[2] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[3] Univ Arizona, Tucson, AZ USA
关键词
D O I
10.1200/jco.2015.33.15_suppl.e16012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16012
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Treatment outcomes in metastatic prostate cancer patients with DNA damage repair mutations
    Kwon, Daniel
    Wright, Francis
    Zhang, Li
    Chou, Jonathan
    Borno, Hala
    Desai, Arpita
    Oh, David Yoonsuk
    Pollock, YaoYao Guan
    Bose, Rohit
    Huang, Franklin W.
    Hope, Thomas
    Friedlander, Terence W.
    Fong, Lawrence
    Feng, Felix Y.
    Small, Eric Jay
    Aggarwal, Rahul Raj
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [22] Mutational Signature Analysis for Detection of DNA Damage Repair Deficiency in Prostate Cancer
    Burdak-Rothkamm, S.
    Alawi, M.
    Droste, C.
    Petersen, C.
    Rothkamm, K.
    JOURNAL OF PATHOLOGY, 2021, 255 : S46 - S46
  • [23] Ancestry-Specific DNA Damage Repair Gene Mutations and Prostate Cancer
    Borbiev, Talaibek
    Babcock, Kevin
    Sinopole, Kayleigh
    Chesnut, Gregory T.
    Petrovics, Gyorgy
    CANCERS, 2025, 17 (04)
  • [24] Anaplastic Features in Advanced Prostate Cancer With and Without DNA Damage Repair Mutations
    Chau, Vincent
    Madan, Ravi A.
    Bilusic, Marijo
    Owens, Helen
    Cordes, Lisa M.
    Marte, Jennifer L.
    Gulley, James L.
    Lee, Jung -Min
    Dahut, William L.
    Karzai, Fatima
    CLINICAL GENITOURINARY CANCER, 2021, 19 (06) : E352 - E359
  • [25] Development and application of DNA damage from PAHs and DNA repair capacity indices to prostate cancer
    Nock, NL
    Rybicki, BA
    Witte, JS
    EPIDEMIOLOGY, 2005, 16 (05) : S91 - S92
  • [26] DNA repair gene panel mutations in young onset and aggressive vs non aggressive prostate cancer cases in the UK
    Eeles, R.
    Saunders, E.
    Wakerell, S.
    Whitmore, I.
    Cieza-Borrella, C.
    Govindasami, K.
    Dadaev, T.
    Kote-Jarai, Z.
    Leongamornlert, D.
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Sigurdson, Alice J.
    Jones, Irene M.
    Wei, Qingyi
    Wu, Xifeng
    Spitz, Margaret R.
    Stram, Douglas A.
    Gross, Myron D.
    Huang, Wen-Yi
    Wang, Li-E
    Gu, Jian
    Thomas, Cynthia B.
    Reding, Douglas J.
    Hayes, Richard B.
    Caporaso, Neil E.
    CARCINOGENESIS, 2011, 32 (01) : 69 - 73
  • [28] Novel serum proteomic biomarkers for early diagnosis and aggressive grade identification of prostate cancer
    Wang, Ce
    Liu, Guangming
    Liu, Yehua
    Yang, Zhanpo
    Xin, Weiwei
    Wang, Meng
    Li, Yang
    Yang, Lan
    Mu, Hong
    Zhou, Chunlei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Defective DNA strand break repair after DNA damage in prostate cancer cells: Implications for genetic instability and prostate cancer progression
    Fan, R
    Kumaravel, TS
    Jalali, F
    Marrano, P
    Squire, JA
    Bristow, RG
    CANCER RESEARCH, 2004, 64 (23) : 8526 - 8533
  • [30] Methylated DNA Markers in Voided Urine for the Identification of Clinically Significant Prostate Cancer
    Shah, Paras
    Taylor, William R.
    Negaard, Brianna J.
    Gochanour, Benjamin R.
    Mahoney, Douglas W.
    Then, Sara S.
    Devens, Mary E.
    Foote, Patrick H.
    Doering, Karen A.
    Burger, Kelli N.
    Nikolai, Brandon
    Kaiser, Michael W.
    Allawi, Hatim T.
    Cheville, John C.
    Kisiel, John B.
    Gettman, Matthew T.
    LIFE-BASEL, 2024, 14 (08):